Unable to secure a profit in immunizing poorer nations, Western multinationals, including Oxford’s private partner AstraZeneca, have prioritized those who can pay the most. (By: Alan Macleod, Mintpress News) Europe is reeling from the shock ...
“It ought to be the people’s vaccine, not a new taxpayer burden.” (By: Jake Johnson, Common Dreams) Consumer advocates warned Wednesday that pharmaceutical giant Moderna is “taking taxpayers for a ride” after the company announced ...